Oregon Adopts First Set of Rules for Legal Psilocybin
Oregon Health Authority did not budge on three rules that the public took issue with.
Travis Reilly is a writer and journalist whose words have appeared in award-winning newspapers, tawdry gossip blogs, and several places in between. When not at his keyboard, he can usually be found tossing tennis balls at the dog park, sipping suds at the local brewery, or scarfing down popcorn at the second-run movie theater.
Oregon Health Authority did not budge on three rules that the public took issue with.
Another Michigan city decriminalizes psychedelic plants and fungi, while Maryland passes a bill to provide military veterans with cost-free access to healing medicines like ketamine, psilocybin, and MDMA.
After a disappointing microdosing study, Dr. Michiel van Elk says the trend is “just not that interesting.”
A double-blinded, randomized, and placebo-controlled study compares the subjective and autonomic effects of both psychedelics.
“Considering all our advocacy on this issue, this employee benefit is the next logical step,” says company president Michael Bronner.
And 94% reported meeting with otherworldly beings during “profound and highly intense experiences.”
“These fungi pose less potential safety risks to consumers,” says Psilocybin Advisory Board mycologist Jessie Uehling.
This week in psychedelic business news: Cybin scores another patent; another huge psychedelics conference heads to Miami; Core One Labs widens pipeline with another drug.
One of Dr. Nirav Shah's chief concerns with the bill is proposed “Psilocybin Service Centers,” which he fears will lean recreational instead of medical.
What do a Tatooine dirt farmer named Luke Skywalker and a would-be psychonaut enrolled at one of Tandava’s psychedelic retreats have in common? Both are about to embark on one heck of a mind-bending “hero’s journey,” at least according to entheogenic entrepreneurs Joël Brierre and Victoria Wueschner. Joël — the CEO and founder of Tandava […]
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.